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The cystic fibrosis transmembrane conductance regulator
(CFTR) is a key membrane protein in the complex network of
epithelial ion transporters regulating epithelial permeability.
Syntaxins are one of themajor determinants in the intracellular
trafficking andmembrane targeting of secretory proteins. In the
present study we demonstrate the biochemical and functional
association between CFTR and syntaxin 16 (STX16) that medi-
ates vesicle transportwithin the early/late endosomes and trans-
Golgi network. Immunoprecipitation experiments in rat colon
and T84 human colonic epithelial cells indicate that STX16
associates with CFTR. Further analyses using the domain-spe-
cific pulldown assay reveal that the helix domain of STX16
directly interacts with the N-terminal region of CFTR. Immu-
nostainings in rat colon and T84 cells show that CFTR and
STX16 highly co-localize at the apical and subapical regions of
epithelial cells. Interestingly, CFTR-associated chloride current
was reduced by the knockdown of STX16 expression in T84
cells. Surface biotinylation and recycling assays indicate that the
reduction in CFTR chloride current is due to decreased CFTR
expression on the plasmamembrane. These results suggest that
STX16 mediates recycling of CFTR and constitutes an impor-
tant component ofCFTR traffickingmachinery in intestinal epi-
thelial cells.
The cystic fibrosis transmembrane conductance regulator
(CFTR)2 is an ion channel that transports chloride ions (Cl).
CFTR plays an important role in the secretion and absorption
of ions and fluid across the luminal surface in diverse epithelia
(1). Cystic fibrosis (CF), the most common genetic disease with
pubescent lethality in Caucasians, is caused by CFTR gene
mutations.Amongmore than 1400 genetic variations identified
to date, loss of the phenylalanine residue at position 508
(F508-CFTR) is the most prevalent disease-causing mutation
and is carried by 90% of CF patients (2). The F508-CFTR
exhibits a trafficking defect that prevents its exit from the endo-
plasmic reticulum (ER) and is eventually targeted for degrada-
tion via ER quality control machinery. However, F508-CFTR
is known to harbor some degree of chloride channel activity
once it reaches the cell surface (2). Characterizing factors
involved inCFTR intracellular traffickingwill help elucidate CF
pathophysiology and provide therapeutic targets to modulate
the biosynthetic pathway of CFTR.
The elements involved in vesicle trafficking and the delivery
of CFTR have been partially identified. Small GTPases, includ-
ing Sar1, Arf1, and Rab proteins affect the processing and traf-
ficking of CFTR (3, 4). Several studies have also demonstrated a
relationship between CFTR and proteins of the soluble N-eth-
ylmaleimide-sensitive factor attachment protein receptor
(SNARE) family, whichmediates the fusion of intracellular ves-
icles with target membranes in eukaryotic cells. Among the
SNARE family, syntaxins (STXs) belong to a subfamily of target
(t)-SNAREs stationed at the target membrane. The SNARE
domain of STX consists of an 60-residue membrane-proxi-
mal coiled-coil domain and mediates membrane fusion
through its interaction with SNARE domains of the cognate
vesicle (v)-SNARE partners found on specific vesicle mem-
branes (5). Recent studies have shown that STXs also interact
with a wide range of proteins other than their cognate SNARE
partners. For example, STX1A and STX3 interact with epithe-
lial cell sodium channels, thereby regulating the intrinsic prop-
erties and cell-surface expression of these channels (6). Inter-
estingly, several syntaxins, such as STX1A and STX13, are also
known to be involved inCFTR trafficking and activity (4, 7), and
current knowledge of STXs associated with CFTR regulation is
listed in supplemental Table 1.
We found that STX16, an additionalmember of syntaxin that
mediates vesicle transport within the early/late endosomes and
trans-Golgi network (TGN) (5, 8), associates with CFTR in a
preliminary screening. The present study aims to examine the
regulation of CFTR via STX16 in the physiologically relevant
conditions. The results in this study suggest that STX16 medi-
ates the apical targeting and/or recycling of CFTR and consti-
tutes an important component of theCFTR traffickingmachin-
ery in intestinal epithelial cells.
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EXPERIMENTAL PROCEDURES
Plasmids, Cell Culture, and Transfection—The pCI-neo-
myc-STX16 plasmid was previously described (9). The pCMV-
CFTRplasmid (pCMVNot6.2)was a gift fromDr J. Rommens at
the Hospital for Sick Children (Toronto, ON, Canada). The
mammalian expressible hemagglutinin (HA)-tagged CFTR
plasmids were constructed using a polymerase chain reaction
(PCR)-based method. Briefly, cDNA encoding the full-length
CFTRwas PCR-amplified frompCMV-CFTR. A fragment con-
taining CFTR was subcloned into a modified pcDNA3.1
(Invitrogen) using the XhoI and NotI restriction sites to con-
struct a plasmid with an HA tag at the N terminus of CFTR
(HAN-CFTR). The N terminus deleted variant of HAN-CFTR
was made by inserting PCR fragment (aa 81-stop codon) into
the HA-tagged pcDNA3.1 using the XhoI and NotI restriction
sites. The CFTR construct with the HA tag at the second extra-
cellular loop of CFTR (HA-CFTR) was made by inserting a
sequence encoding the amino acids ASYDHSRNNYPYDVP-
DYASYAVIPDNK between Glu-217 and Leu-218 of CFTR
according to the protocol described previously (3). The C ter-
minus-deleted variants of HA-CFTR were made by generating
stop codons at the designated sites using a PCR-based
mutagenesis technique. Four glutathione S-transferase (GST)
fusion domains of CFTR (N-term (aa 1–79), NBD1 (aa 433–
584), NBD2 (aa 1219–1382), and C-term (aa 1387–1480)) were
generated by inserting PCR fragments amplified from pCMV-
CFTR into EcoRI/NotI sites of the bacterial expression vector
pGEX-4T-1 (GE Healthcare). Four histidine His6 fusion
domains of STX16 were generated by inserting PCR fragments
(N-term (aa 1–77), Habc (aa 78–239), SNARE (aa 234–302),
TM (aa 1–302)) into the bacterial expression vector pET-
28c() (Novagen, Darmstadt, Germany) using EcoRI/NotI or
EcoRI/XhoI sites.
HEK 293 cells were maintained in high glucose Dulbecco’s
modified Eagle’s medium (DMEM-HG; Invitrogen) supple-
mented with 10% fetal bovine serum, penicillin (50 IU/ml), and
streptomycin (50g/ml). Plasmidswere transiently transfected
into HEK 293 cells using Lipofectamine Plus Reagent (Invitro-
gen). T84 human colonic epithelia cells were maintained in a
1:1 mixture of Ham’s F-12 medium and DMEM supplemented
with 10% fetal bovine serum, penicillin (50 IU/ml), and strep-
tomycin (50 g/ml). The STX16-specific or control scrambled
small interfering (si) RNAs were purchased from Qiagen
(Valencia, CA). siRNAs or plasmids were transiently trans-
fected into T84 cells using Lipofectamine 2000 (Invitrogen).
Transfection efficiency of 90% for the siRNA treatment was
confirmed in T84 cells using FITC-labeled siRNA and conven-
tional epifluorescence microscopy.
Immunoblotting, Immunoprecipitation, and Immunocytochem-
istry—Immunoblotting and immunoprecipitation were per-
formed as described previously (10). For immunoprecipitation,
cell and tissue lysates weremixedwith the appropriate antibod-
ies and incubated overnight at 4 °C in a lysis buffer containing
50mMTris-HCl (pH 7.4), 200mMNaCl, 1% (v/v) Nonidet P-40,
0.25% (v/v) sodiumdeoxycholate, and complete protease inhib-
itormixture (RocheApplied Science). Immune complexeswere
collected by binding to mixed protein A/G beads and then
washed four times with lysis buffer prior to electrophoresis. For
immunoblotting, protein samples were suspended in a sodium
dodecyl sulfate (SDS) buffer and separated by SDS-polyacryl-
amide gel electrophoresis. The separated proteins were trans-
ferred to a nitrocellulosemembrane and blotted with appropri-
ate primary and secondary antibodies. Protein bands were
detected by enhanced chemiluminescence (Amersham Bio-
sciences), and the staining intensities of immunoblots were
analyzed using imaging software (Multi Gauge Version 3.0,
Fujifilm, Valhalla, NY).
For immunocytochemistry, T84 cells were fixed and perme-
abilized by incubation in cold methanol for 10 min at20 °C 3
days after transfection. Immunostaining of frozen sections was
performed as described previously (11). Briefly, colon tissues
from Sprague-Dawley rats were embedded in optimal cutting
temperature (OCT) compound (Miles, Elkhart, IN), frozen in
liquid nitrogen, and then cryosectioned into 4-m sections.
Nonspecific binding sites were blocked by incubation for 1 h at
room temperature with 0.1 ml of phosphate-buffered saline
(PBS) containing 5%goat serum, 1%bovine serumalbumin, and
0.1% gelatin (blocking medium). After blocking, cells were
stained by incubation with appropriate primary antibodies and
then treated with fluorophore-tagged secondary antibodies.
Image analyses were carried out using MetaMorph software
(Molecular Devices, Sunnyvale, CA). Anti-STX16 was de-
scribed previously (12), and anti-CFTR M3A7 (Millipore, Bil-
lerica, MA), anti-calnexin (Abcam, Cambridge, MA), anti-BiP
(Cell Signaling, Inc., Danvers, MA), anti- actin, anti-HA, anti-
Myc, anti-His, and anti-Aldolase A (Santa Cruz Biotechnology,
Santa Cruz, CA) antibodies were purchased from commercial
sources. Rabbit polyclonal anti-CFTR antibody (R4) was raised
against peptides corresponding to amino acids at 1458–1471 of
human CFTR (CKSKPQIAALKEET) and affinity-purified.
SubcellularFractionation—Subcellularfractionationwasper-
formed as described previously (13). Culture dishes (100 mm)
of T84 cells were rinsed 3 times with 10 ml of HES buffer con-
taining 255 mM sucrose, 20 mM HEPES (pH 7.4), and 1 mM
EDTA. Cells were harvested in HES buffer (4 ml) containing
complete protease inhibitor mixture and homogenized. The
homogenate was centrifuged at 19,000  g for 20 min. The
resulting supernatant was centrifuged at 41,000 g for 20 min
to yield a high density microsome fraction pellet. Then the
supernatant was further centrifuged at 180,000 g for 75 min
to yield a low density microsome pellet. The pellet obtained
from the initial centrifugation step was layered onto 1.12 M
sucrose in HES buffer and centrifuged at 100,000 g in a Beck-
man SW-41 rotor for 60min. This yielded a white fluffy band at
the interface (plasma membrane fraction) and a viscous brown
pellet (mitochondria/nuclei fraction). The plasma membrane
fraction was resuspended in 1 ml of HES and pelleted at
40,000 g for 20 min.
Surface Biotinylation—Surface biotinylation of CFTR was
performed as described previously (10). T84 cells were grown
on a permeable support (Corstar Transwell, Corning Life Sci-
ences, NY) to formmonolayers, and siRNAswere transfected at
day 6. The siRNA transfection was repeated twice with 3-day
intervals. Forty-eight hours after the second siRNA transfec-
tion, T84 cells were cooled to 4 °C and washed three times with
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PBS. The plasmamembrane proteins were then biotinylated by
gently shaking the cells in PBS buffer containing sulfo-NHS-SS-
biotin (Pierce) for 30 min. After biotinylation, cells were
washed extensively with quenching buffer to remove excess
biotin and thenwashed twicewith PBS.The cellswere lysed and
incubated overnight at 4 °C with avidin solution (UltraLink
Immobilized NeutrAvidin Beads 10%, Pierce). Avidin-bound
complexes were pelleted by centrifugation at 13,000 rpm and
washed 3 times. Biotinylated proteins were eluted in 2 sample
buffer, resolved by SDS-PAGE, electrotransferred, and immu-
noblotted with anti-CFTR M3A7.
Apical Recycling Assay—Apical recycling of internalized
CFTR was assayed in T84 cells as described previously (14).
Because it is difficult to positively visualize the recycled CFTR,
the amount of apically recycled CFTR was estimated by sub-
tracting non-recycled CFTR from total internalized CFTR.
Briefly, the plasma membrane proteins were biotinylated and
then internalized for 30 min at 37 °C. Proteins remaining at the
cell surface after 30 min were stripped of biotin with four
15-min washes in the sodium 2-mercaptoethanesulfonate
stripping buffer (50 mM MESNA, 150 mM NaCl, 1 mM EDTA,
0.2% BSA, and 20 mM Tris (pH 8.6)). To detect the recycling of
internalized, biotinylated CFTR, T84 cells were incubated at
37 °C and stimulated with 5 M forskolin for 0, 5, 10, or 20 min
and then quickly cooled to 4 °C. Biotinylated CFTR that is recy-
cled to the plasmamembrane was then stripped of biotin by the
MESNA buffer washes. The remaining non-recycled biotinyl-
ated CFTR was detected as described above.
Pulldown Assays—The pulldown assay was performed as
described previously (15). All recombinant fusion proteins
were produced in BL-21 (DE3) Escherichia coli strain. Briefly,
synthesis of GST fusion and His6 fusion proteins was induced
by 0.5 mM isopropyl -D-1-thiogalactopyranoside at 30 °C.
Recombinant proteins were subsequently purified with gluta-
thione-SepharoseTM beads (Amersham Biosciences) or with a
nickel-nitrilotriacetic acid protein purification system (Qiagen)
according to the manufacturer’s instructions. Eluted His6
fusion proteins were mixed with 50 g of GST fusion recombi-
nant proteins bound to glutathione-SepharoseTM. After over-
night incubation at 4 °C, bead-bound complexes were washed,
eluted in SDS sample buffer, and immunoblotted.
Measurement of ClChannel Activities—Whole-cell record-
ings were performed on T84 cells as reported previously (16).
Cl currents were isolated by using Cl as the only permeant
FIGURE 1. Effect of STX16 depletion on CFTR current in T84 cells. A, subcellular localization of STX16 in T84 cells is shown. Plasma membrane (PM), high
densitymicrosome (HDM), lowdensitymicrosome (LDM), and cytosol fractionswerepreparedbydifferential centrifugation. Fractionswere immunoblotted for
CFTR and STX16. Each lane was loaded with 20 g of protein except for CFTR cell lysate (100 g). B, protein samples were obtained from T84 cells 48 h after
transfection with the control scrambled (100 nM) or STX16-specific (50 or 100 nM) siRNA. Equal amounts of protein samples (20g) were immunoblotted with
STX16 and -actin antibodies. A summary of three separate experiments is presented in the right panel. C, the cAMP-activated Cl channel activity was
measured in the whole-cell configuration. The current-voltage (I-V) relationships were obtained with a step pulse from 120 to  120 mV applied at peak
current. T84 cells were pretreated with the control or STX16-specific siRNA (100 nM) for 48 h. Treatment with forskolin (5 M), an adenylyl cyclase activator,
evoked a Cl current that was sensitive to the CFTR inhibitor CFTRinh-172 (10M) in T84 cells.D, a summary of CFTR channel activity measurements is shown.
Mean currents measured at 40 mV holding potential were normalized as current densities (pA/pF; cells transfected with control siRNA, n  14; cells
transfected with STX16 siRNA, n 11). E, a summary of volume-sensitive Cl channel (VoCC) activity measurements is shown. The current was activated by
reducing the osmolarity of the bath solution from 323 to 278 mosM (cells with control siRNA, n  10; cells with STX16 siRNA, n  9). F, a summary of
Ca2-activatedCl channel (CaCC) activitymeasurements is shown. The currentwas activatedby 400nM free Ca2 in pipette solution (cellswith control siRNA,
n 13; cells with STX16 siRNA, n 14). **, p 0.01, difference from control; ns, not significant.
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ion in the pipette and bath solutions. For CFTR currents, the
pipette solution contained 140 mM N-methyl-D-glucamine
chloride (NMDG-Cl), 5 mM EGTA, 1 mM MgCl2, 1 mM Tris-
ATP, and 10 mM HEPES (pH 7.4), and the bath solution con-
tained 140 mM NMDG-Cl, 1 mM CaCl2, 1 mM MgCl2, 10 mM
glucose, and 10 mM HEPES (pH 7.4). CFTR was activated by
adding forskolin and 3-isobutyl-1-methylxanthine. The hold-
ing potential was40 mV. For volume-sensitive Cl currents,
the pipette solution contained 145mMNMDG-Cl, 5mMEGTA,
1 mM MgCl2, 3 mM Mg-ATP, and 20 mM HEPES (pH 7.4), and
the bath solution contained 126 mM NMDG-Cl, 1 mM CaCl2, 1
mM MgCl2, 10 mM glucose, 10 mM HEPES (pH 7.4), and/or 45
mM sorbitol. For Ca2-activated Cl currents, the pipette solu-
tion contained 147 mM NMDG-Cl, 10 mM EGTA, 6.93 mM
CaCl2, 1mMMgCl2, 3mMMg-ATP, and 10mMHEPES (pH7.4)
(free Ca2 concentration 400 nM), and the bath solution con-
tained 148mMNMDG-Cl, 1 mMMgCl2, 10mM glucose, and 10
mM HEPES (pH 7.4).
All experiments were performed at room temperature, and
the current output was filtered at 5 kHz. Currents were digi-
tized and analyzed using an AxoScope 8.1 system and a Digi-
data 1322A analog/digital converter (Axon Instruments,
Union City, CA). Mean currents were normalized as current
densities (pA/pF). CFTRinh-172, a
CFTR inhibitor was purchased from
Sigma.
RESULTS
Depletion of STX16 Down-regu-
lates CFTR Channel Activity—We
first investigated STX16 distribu-
tion in T84 colonic epithelial cells,
which endogenously express CFTR
and STX16. Among the known
splice variants of human STX16
(17), STX16A, 16B, and 16H iso-
forms harbor a single transmem-
brane domain, whereas STX16C
and 16D isoforms are cytosolic pro-
teins that lack the transmembrane
domain. To determine the subcellu-
lar localization of STX16 in T84
cells, cellular compartments were
fractionated by differential centrifu-
gation (Fig. 1A). The high density
microsome fraction contains large
endosomal components and the ER,
whereas the low density microsome
fraction contains Golgi endosomes
and small vesicles. Cellular fraction-
ation followed by immunoblotting
showed that CFTR was primarily
observed in the plasma membrane
fraction, and STX16was detected in
the plasma membrane, high density
microsome, and low density micro-
some fractions but not in the
cytosol. Therefore, STX16 is pres-
ent largely in membrane-bound forms in T84 cells. Further
identification by reverse transcription PCR using isoform-spe-
cific primers revealed that STX16A (isoform b in the National
Center for Biotechnology Information data base, www.
ncbi.nlm.nih.gov) is the major isoform expressed in T84 cells
(supplemental Fig. 1 and supplemental Table 2).
Weused a siRNA-mediated expression silencing approach to
determine the role of STX16 on CFTR function in epithelial
cells. Initially, the efficiency of siRNA directed against STX16
was assessed in T84 cells (Fig. 1B). STX16 expression was
decreased by 77.2 	 6.3% in cells transfected with STX16
siRNA (100 nM) comparedwith scrambled siRNA-treated cells.
The effect of STX16 depletion on CFTR channel activity was
measured with the whole-cell patch clamp technique (Fig. 1C).
Treatment with forskolin, an adenylyl cyclase activator, evoked
a large cAMP-stimulated CFTR-induced inward current that
was sensitive to the CFTR inhibitor CFTRinh-172 (Fig. 1C).
Notably, STX16 depletion induced a remarkable reduction in
the CFTRCl channel activity. The CFTR current density (pA/
pF) was decreased by 42.6	 5.3% in STX16-depleted cells (Fig.
1D). However, STX16 knockdown had no significant effect on
the volume-sensitive (VoCC) and Ca2-activated (CaCC) Cl
FIGURE2.CFTRandSTX16associate in vivo.A, co-immunoprecipitation (IP) of STX16andCFTR in T84 cell and
rat colon is shown. Protein samples were precipitated with control (nonimmune IgG) and anti-CFTR M3A7.
Immunoblotting was then carried out using anti-STX16. Co-immunoprecipitation was performed with a total
of 1 mg lysate, and each lane in lysate blot was loaded with 60 g of protein. B, rat colon slices were immun-
ofluorescently stained with anti-STX16 (red) and anti-CFTR M3A7 (green). The nuclei were stained with 4
,6-
diamidino-2-phenylindole (DAPI). C, localization of CFTR and STX16 in T84 monolayers is shown. Exogenous
CFTR was additionally expressed using transient transfection with pCMV-CFTR. Fluorescent images of the
vertical z axis sectionwereobtained after stainingwith anti-STX16 (red) and anti-CFTR (green) using aZeiss LSM
510 confocal microscope. Fluorescence intensities of the various emissions were analyzed with MetaMorph
software.
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currents (Fig. 1, E and F), indicating that STX16 depletion spe-
cifically affects CFTR activity in T84 cells.
Physical Interaction between STX16 and CFTR—To explore
underlying mechanisms involved in the STX16-mediated reg-
ulation of CFTR, physical interaction between STX16 and
CFTR was examined. In T84 cells and rat colon, which endog-
enously express both STX16 and CFTR proteins, immune-
complexes precipitated by the anti-CFTRM3A7 antibody con-
tained STX16, suggesting that native CFTR and STX16
associate in a protein complex (Fig. 2A). Next, the relationship
between CFTR and STX16 was evaluated by double immuno-
staining in rat colonic mucosa (Fig. 2B). STX16 was highly
expressed in the apical and subapical regions of colonic crypt
cells, and CFTR was concentrated in the apical area. Conse-
quently, STX16 colocalized with CFTR near the apical regions,
where CFTR plays a major role in ion transport and fluid secre-
tion. To further determine the specific subcellular localization
of STX16 bound to CFTR, T84 cells were cultured on a perme-
able support and immunostained. To enhance the visibility of
CFTR protein, exogenous CFTR was additionally expressed
using transient transfection with pCMV-CFTR. Localizations
of CFTR and STX16 in the polarized T84 monolayers were
examined using fluorescent images of the vertical z axis sec-
tions, and fluorescence intensities of CFTR (green) and STX16
(red) were quantified with Meta-
Morph software (Fig. 2C). Expres-
sion of CFTR was highly concen-
trated at the apical membrane and
subapical regions of T84 epithelial
cells. STX16 was abundantly ex-
pressed at the subapical and central
regions of epithelial cells, where
recycling endosomes and TGN are
localized. Consequently, CFTR and
STX16 were highly colocalized at
the subapical regions of the polar-
ized T84 monolayers (Fig. 2C,
yellow).
To identify the CFTR domain
that interacts with STX16, co-im-
munoprecipitation was performed
inHEK 293 cells using deletion con-
structs of CFTR (Fig. 3A). The co-
immunoprecipitation results sug-
gest that the N terminus of CFTR is
required for interactionwith STX16
(Fig. 3, B and C). However, the N
terminus deletion of CFTR evoked a
processing defect and eliminated
the mature complex-glycosylated
form of CFTR (band C) in lysate
immunoblot (Fig. 3C). It has already
been shown that deletion of CFTR
N terminus disrupts normal CFTR
biosynthesis and maturation in
mammalian cells (18, 19). There-
fore, to confirm the co-immunopre-
cipitation result and further charac-
terize the interaction, GST pulldown assays were performed.
Cytosolic domains of CFTR and STX16 were GST- and His6-
tagged, respectively (Fig. 4, A and C). Then, the GST-tagged
CFTR domains (GST-CFTR-N-term, GST-CFTR-NBD1,
GST-CFTR-NBD2, and GST-CFTR-C-term) were incubated
with the His6-tagged cytosolic domain of STX16 (His6-STX16-
TM), and proteins bound to glutathione beads were blotted
with the anti-His antibody. Consistent with the co-immuno-
precipitation results, the CFTRN terminus was responsible for
interaction with STX16 (Fig. 4B). Next, to identify the CFTR
interacting domain in STX16, three His6-tagged truncated
STX16 proteins (N terminus (His6-STX16-N-term), middle
helix-containing region (His6-STX16-Habc), and SNARE
domain (His6-STX16-SNARE)), were incubated with GST-
CFTR-N-term, and protein samples were purified with gluta-
thione beads. The pulldown assay showed thatmiddle region of
STX16, which contains helices a, b, and c (Habc) (20), binds to
the N terminus of CFTR (Fig. 4D). Taken together, these data
indicate that STX16 directly associates with the CFTRN termi-
nus via its Habc-containing helix domain and is co-localized
with CFTR at the apical and subapical regions of colonic epi-
thelial cells.
Molecular Mechanism of CFTR Regulation by STX16—Two
possibilities were examined to determine the molecular mech-
FIGURE 3.Domain-specific protein-protein interaction between STX16 and CFTR. A, a schematic diagram
of CFTR variants used in this study is shown. B and C, HEK 293 cells were transiently transfected with the
HA-tagged CFTR variants and/or Myc-tagged STX16 plasmids. Protein samples were precipitated with anti-
CFTR M3A7, and immunoblotting was performed with anti-Myc (STX16). In immunoblotting, 50 and 10 g of
proteins were loaded into each lane for CFTR and STX16, respectively, and immunoprecipitation (IP) was
performed with a total of 500 g cell lysate. band B, ER core-glycosylated CFTR; band C, mature complex-
glycosylated CFTR; full, full-length; NBD, nucleotide binding domain; TM, transmembrane domain; R, regula-
tory domain.
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anism that is responsible for STX16
depletion-induced reduction in the
CFTR Cl channel activity (Fig.
1D). The first possibility is reduced
membrane expression of CFTR.
SNARE proteins are involved in the
sorting, trafficking, and endocytic
recycling of cargo proteins (20).
Therefore, STX16 may coordinate
these processes involved in the
CFTR surface expression. Surface
biotinylation was performed in T84
cells after transfection with the con-
trol scrambled or STX16 siRNAs.
As shown in Fig. 5, STX16 silencing
reduced CFTR membrane expres-
sion by 62.8 	 6.9% without affect-
ing total amount of CFTR protein in
cell lysates. Furthermore STX16
depletion had no significant effect
upon the surface expression of the
Ca2-activated chloride channel,
Ano1/TMEM16A. This result sug-
gests that STX16 mediates CFTR
surface expression by facilitating
either the anterograde trafficking of
CFTR or the recycling of endocy-
tosed CFTR.
STX16 was shown to be involved
in recycling endosome-to-TGN ret-
rograde transport (12) andmediates
insulin-stimulated glucose trans-
porter 4 transport to the surface
membrane (21). Therefore, the role
of STX16 in CFTR recycling was
examined using the apical recycling
assays of surface-biotinylated pro-
tein in polarized T84 monolayers.
Cells were stimulated with forskolin
after clearing residual surface bio-
tinylated protein with MESNA,
because activation of protein kinase
A facilitates CFTR trafficking from
intracellular compartments to the
plasma membrane (22). In T84 cells
transfected with control siRNA,
74.6 	 7.4% of internalized CFTR
recycled to the plasma membrane
during a10-min forskolin stimula-
tion. However, depletion of STX16
decreased this value to 45.3 	 7.3%
(Fig. 6). Thus, the proper copy num-
ber of CFTR channels on the plasma
membrane ismaintained by STX16-
mediated CFTR recycling.
The second potential mechanism
by which STX16 depletion inhibits
CFTR Cl channel activity could be
FIGURE 4. In vitro interaction between STX16 and CFTR. A, shown is a schematic diagram of the CFTR
cytosolic domains fused with GST that were used for pulldown assays. B, expressions of GST-fused CFTR
domains are visualized by the Ponceau S stain (upper panel). GST pulldown assays were performed using
10 g of purified recombinant His6-tagged STX16-TM and 50 g of each GST-fusion protein (lower
panel). C, shown is a schematic diagram of STX16 domains tagged with His6. D, expressions of His6-tagged
STX16 domains used in pulldown assays are visualized by the Coomassie Brilliant Blue staining (left panel).
GST pulldown assays were performed using 50 g of the GST-fused N terminus tail of CFTR (GST-CFTR-N-
term) and 10g of each purified recombinant His6-tagged STX16 domains (right panel). In the control lane
in immunoblots, 1 g of each His6-tagged protein was loaded. TM, transmembrane domain.
FIGURE 5. Effect of STX16 depletion on the surface expression of CFTR in T84 cells. T84 monolayers were
transfectedwith control or STX16-specific siRNA (100nM). The siRNA transfectionmethodwasdescribedunder
“Experimental Procedures.” A, surface-biotinylated proteins and whole cell lysates were immunoblotted with
anti-CFTR, anti-ANO1, anti-BiP, anti-calnexin, anti-STX16, and anti--actin. Cell surface-specific labeling of pro-
teinswas confirmed by the absence of ER-localized proteins (calnexin and BiP) in the biotinylated fraction. The
amount of surface-biotinylated proteins (B) and cell lysates (C) was quantifiedwith theMulti Gauge Version 3.0
software package (n 3). **, p 0.05, difference from control.
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due to a direct effect of STX16 on CFTR channel function.
STX1A was previously shown to modulate CFTR-mediated
Cl current via a direct protein-protein interaction with the
CFTR N terminus (7, 18). To investigate this possibility, we
performed whole-cell patch clamp in T84 cells using a patch
pipette containing recombinant STX16 lacking the trans-
membrane domain (STX16-TM) (Fig. 7). In control exper-
iments, inclusion of the cytosolic domain of STX1A
(STX1A-TM) in the patch pipette solution resulted in a
2–3-fold increase of CFTR currents within 10 min of mem-
brane rupture by patch pipette (Fig. 7) as previously
described (7). Treatment with STX1A-TM augments
CFTR currents by disrupting interactions with endogenous
membrane-anchored STX1A that normally attenuates the
activity of native CFTR in T84 cells (7). However, inclusion
of the cytosolic domain of STX16 (STX16-TM) in the patch
pipette produced no acute effects on the CFTR chloride cur-
rent in T84 cells (Fig. 7). Taken together, the above results
suggest that STX16 regulates CFTR activity by increasing
surface abundance via its membrane trafficking SNARE
function rather than directly affecting CFTR channel.
DISCUSSION
The present study provides direct evidence that STX16 is a
part of theCFTR traffickingmachinery and regulates its surface
expression in polarized epithelial cells. Several lines of evidence
support a role of STX16 inCFTR trafficking and surface expres-
sion. First, the CFTRN terminusmediates its direct interaction
with STX16 (Figs. 2–4). TheN terminus of CFTR seems to play
an important role for its intracellular trafficking and process-
ing. Among syntaxins, STX1Aand endosomal SNAREs, includ-
ing STX7 andSTX8, are known to bind to theCFTRN terminus
(18, 23). Filamins, which are actin-binding proteins that stabi-
lize CFTR at the cell surface, and the cysteine string protein,
which is a chaperone that modulates CFTR maturation, also
bind to the N terminus of CFTR (19, 24). In addition, the N
terminus contains an internalization signal that appears to be
important for CFTR endocytosis by an unknown mechanism
(25).
Second, STX16 depletion decreases CFTR surface expres-
sion (Figs. 5 and 6). It has been reported that Tlg2p, the yeast
homologue of mammalian STX16, is localized to the TGN and
early endosomes and up-regulates the membrane trafficking of
proteins such as casein kinases (26, 27). The glucose transporter
FIGURE 6. Effect of STX16 depletion on the apical recycling of CFTR in
T84 cells. Apical recycling was assayed in T84 monolayers. The plasma
membrane proteins on apical sidewere biotinylated and then internalized
for 30 min at 37 °C. Proteins remaining at the cell surface were stripped of
biotin with the sodium 2-mercaptoethanesulfonate stripping buffer.
Recycling of internalized, biotinylated CFTR was stimulated with 5 M
forskolin for 5, 10, or 20 min. Non-recycled, biotinylated proteins were
collected and immunoblotted. A, representative CFTR immunoblot of api-
cal recycling assays in T84 monolayers transfected with scrambled or
STX16-specific siRNA is shown. Lane 1, total apical membrane CFTR; lane 2,
sodium 2-mercaptoethanesulfonate (MESNA) stripping control; lane 3,
internalized CFTR after 30 min at 37 °C; lanes 4, 5, and 6, internalized CFTR
that remained in the cells after 5, 10, and 20 min forskolin stimulation (5
M). The difference between lanes 3 and lanes 4, 5, and 6 represents recy-
cled CFTR. B, shown is quantitative analysis of apical CFTR recycling in T84
cells transfected with control or STX16 siRNA (n  4).
FIGURE 7. Effect of STX16 cytosolic domain on the CFTR channel activity.
Whole cell Clcurrents were measured with patch pipettes containing the
purified recombinant cytosolic domain of STX16 (His6-STX16-TM). The cyto-
solic domain of STX1A (His6-STX1A-TM) was used as a positive control.
A, cAMP-activated Cl channel activity was determined in T84 cells using
patch pipettes containing 0, 100, 500 nM His6-STX16-TM or 500 nM of His6-
STX1A-TM. Cells were stimulated with forskolin (5 M), and currents were
measured after a 10-min equilibration with pipette solution that contained
recombinant proteins. The current-voltage (I-V) relationships were obtained
with a step pulse from 100 to  100 mV applied at peak current. B, mean
currents measured at40 mV holding potential were normalized as current
densities (pA/pF; 0 nM STX16-TM, n 7; 100 nM STX16-TM, n 11; 500 nM
STX16-TM, n 7; 500 nM STX1A- TM, n 6).
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glucose transporter 4 recycles to the cell surface via a STX16-
dependent mechanism (6, 21). In accordance with previously
identified functions of STX16, we demonstrate here that
STX16 facilitates surface expression of CFTR on the apical
membrane of epithelial cells. The fact that STX16 is linked to
early/recycling endosome-to-TGN retrograde transport indi-
cates that it may be involved in the surface recycling of CFTR
via TGN (Fig. 7). Several Rab GTPases, which regulate endo-
some-to-TGN transport, have been shown to affect CFTR
intracellular trafficking. Rab11 controls early endosome-to-
TGN trafficking of CFTR and its recycling by an Rme1-depen-
dent vesicular transport mechanism (3, 28). In addition, Rab9
mediates CFTRmembrane transport via the late endosome-to-
TGN pathway (3). The precise role of STX16 in CFTR traffick-
ing as well as the cognate SNARE partners involved requires
further investigation.
SNAREs play an important role in intracellular trafficking of
ion channels and transporters. As members of the (t)-SNARE
protein family, several syntaxins have been suggested to be
involved in the intracellular trafficking and regulation of CFTR.
Asmentioned earlier, STX1Ahas been shown to regulateCFTR
channel activity directly through a protein-protein interaction
(7, 18, 29). In addition, it has been reported that overexpression
of STX5, which is required for the fusion of coat protein com-
plex II (COPII) transport vesicles with acceptor Golgi mem-
branes, inhibits CFTR processing in some cell lines and that
overexpression of STX13, which resides in early and late recy-
cling endosomes, blocks CFTR maturation in baby hamster
kidney cells (4). However, CFTR trafficking in heterologous
expression systems does not exactly reflect that in polarized
epithelial cells (14, 30).
We have initially studied the effects of STX16 on CFTR traf-
ficking in non-polarized HEK 293 cells. Overexpression of
STX16 increased the surface expression and current density of
CFTR (supplemental Fig. 2). Interpretation of these results
should be done carefully and with appropriate reservations,
because the consequences of STX overexpression could be
complex and unpredictable. Overexpression of STXsmay rein-
force the action of these proteins or may actually inhibit their
action by disrupting the stoichiometric balance in relation to
other SNARE proteins (23). For example, overexpression of
wild type STX6 was shown to increase tumor necrosis factor-
(TNF) surface delivery and secretion, whereas overexpression
of a dominant negative cytoplasmic STX6 reducedTNF deliv-
ery (31). Contrastingly, overexpression resulted in loss-of-func-
tion for certain STXs, including STX5, which hindered the ER-
to-Golgi transport of vesicular stomatitis virus G protein (4),
and STX7 and STX8, which inhibited the apical targeting of
CFTR (23). In addition, the effect of STX overexpression
depends on the cell types concerned. Overexpression of STX5
inhibited the ER-to-Golgi transport of CFTR in HEK 293T and
HeLa cells but not in baby hamster kidney cells (4). In the case
of STX16, its overexpression in HEK 293 cells showed gain-of-
function effects onCFTR expression and function (supplemen-
tal Fig. 2), which are comparable with those observed in T84
cells (Figs. 1 and 5).
Another important group of proteins that is involved in the
regulation of CFTR expression and activity is PDZ (PSD-95/
discs large/ZO-1)-based adaptor proteins including NHERFs
and Shank2 (15, 32). BothNHERFs and Shank2 increase surface
expression of CFTR, although they exert opposite effects on
cAMP-induced activation of CFTR Cl channel activity (11,
33). Interestingly, some PDZ proteins, such as FIG/CAL and
syntenin-1, have been shown to associate with STXs and par-
ticipate in the intracellular trafficking of CFTR and othermem-
brane proteins (34–36). Therefore, it will also be an interesting
subject to investigate whether PDZ-based adaptors are
involved in the effects of STX16 on CFTR trafficking.
Considering its rapid internalization and relatively low trans-
lation rate, the recycling of endocytosed CFTR is essential to
maintain the proper number of functional CFTR at the cell
surface (37). The maintenance of steady-state cell surface level
of CFTR is primarily due to recycling of internalized CFTR
rather than insertion of newly synthesized CFTR (28). The
F508-CFTR mutant has a folding defect and is mostly
degraded by the ER-associated degradation pathway. Some
maneuvers, such as low temperature incubation, and small
molecules called correctors can partially correct processing
defects of F508-CFTR and facilitate its delivery to the surface
membrane. However, F508-CFTR exhibits a markedly
reduced cell surface stability compared with wild type CFTR (3,
38). Studies have demonstrated an almost 10-fold decrease in
the surface half-life of F508-CFTR (39). Interestingly, overex-
pression of STX16 increased the membrane expression of
F508-CFTR that was rescued by the low temperature incuba-
tion (27 °C), whereas depletion of STX16 by siRNA showed the
opposite effect in HEK 293 cells (supplemental Fig. 3). These
results imply that the reduced surface half-life of F508-CFTR
can be overcome at least partially by increasing the efficiency of
recycling.
In summary, our results indicate that STX16 actively partic-
ipates in the trafficking and recycling of CFTR. Understanding
the mechanism by which STX16 modulates CFTR activity will
contribute to develop therapeutic strategies to treat CF that is
caused by aberrant intracellular trafficking of membrane
proteins.
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